lobenzarit has been researched along with sym-trinitrobenzene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mihara, M; Nakano, T; Ohsugi, Y | 1 |
1 other study(ies) available for lobenzarit and sym-trinitrobenzene
Article | Year |
---|---|
An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Autoimmune Diseases; B-Lymphocytes; DNA, Single-Stranded; Immunoglobulins; Longevity; Lymphocyte Activation; Lymphoid Tissue; Male; Mice; Mice, Mutant Strains; ortho-Aminobenzoates; Proteinuria; Rheumatoid Factor; Trinitrobenzenes | 1987 |